222 related articles for article (PubMed ID: 37158834)
1. Proteogenomic characterization of ferroptosis regulators reveals therapeutic potential in glioblastoma.
Wang X; Zhang H; Zhang M; Zhang X; Mao W; Gao M
BMC Cancer; 2023 May; 23(1):415. PubMed ID: 37158834
[TBL] [Abstract][Full Text] [Related]
2. Ferroptosis Suppressive Genes Correlate with Immunosuppression in Glioblastoma.
Deng S; Zheng Y; Mo Y; Xu X; Li Y; Zhang Y; Liu J; Chen J; Tian Y; Ke Y
World Neurosurg; 2021 Aug; 152():e436-e448. PubMed ID: 34062295
[TBL] [Abstract][Full Text] [Related]
3. CircRNF10 triggers a positive feedback loop to facilitate progression of glioblastoma via redeploying the ferroptosis defense in GSCs.
Wang C; Zhang M; Liu Y; Cui D; Gao L; Jiang Y
J Exp Clin Cancer Res; 2023 Sep; 42(1):242. PubMed ID: 37723588
[TBL] [Abstract][Full Text] [Related]
4. Inhibitory effects of temozolomide on glioma cells is sensitized by RSL3-induced ferroptosis but negatively correlated with expression of ferritin heavy chain 1 and ferritin light chain.
Yang FC; Wang C; Zhu J; Gai QJ; Mao M; He J; Qin Y; Yao XX; Wang YX; Lu HM; Cao MF; He MM; Wen XM; Leng P; Cai XW; Yao XH; Bian XW; Wang Y
Lab Invest; 2022 Jul; 102(7):741-752. PubMed ID: 35351965
[TBL] [Abstract][Full Text] [Related]
5. Comparative proteogenomic characterization of glioblastoma.
Asif S; Fatima R; Krc R; Bennett J; Raza S
CNS Oncol; 2019 Jun; 8(2):CNS37. PubMed ID: 31290679
[No Abstract] [Full Text] [Related]
6. FHOD1 is upregulated in glioma cells and attenuates ferroptosis of glioma cells by targeting HSPB1 signaling.
Zhang F; Wu L; Feng S; Zhao Z; Zhang K; Thakur A; Xu Z; Liang Q; Liu Y; Liu W; Yan Y
CNS Neurosci Ther; 2023 Nov; 29(11):3351-3363. PubMed ID: 37211949
[TBL] [Abstract][Full Text] [Related]
7. Ferroptosis Modulation: Potential Therapeutic Target for Glioblastoma Treatment.
de Souza I; Ramalho MCC; Guedes CB; Osawa IYA; Monteiro LKS; Gomes LR; Rocha CRR
Int J Mol Sci; 2022 Jun; 23(13):. PubMed ID: 35805884
[TBL] [Abstract][Full Text] [Related]
8. Glioblastoma Relapses Show Increased Markers of Vulnerability to Ferroptosis.
Kram H; Prokop G; Haller B; Gempt J; Wu Y; Schmidt-Graf F; Schlegel J; Conrad M; Liesche-Starnecker F
Front Oncol; 2022; 12():841418. PubMed ID: 35530303
[TBL] [Abstract][Full Text] [Related]
9. Modulation of Tumor Immune Microenvironment and Prognostic Value of Ferroptosis-Related Genes, and Candidate Target Drugs in Glioblastoma Multiforme.
Zhang X; Jin S; Shi X; Liu S; Li K; Liu G; Zhong S; Liu T; Li L; Tao S; Zhai Q; Bao N; Ren L; Wu Y; Bao Y
Front Pharmacol; 2022; 13():898679. PubMed ID: 35571123
[TBL] [Abstract][Full Text] [Related]
10. Identification of SSBP1 as a ferroptosis-related biomarker of glioblastoma based on a novel mitochondria-related gene risk model and in vitro experiments.
Su J; Li Y; Liu Q; Peng G; Qin C; Li Y
J Transl Med; 2022 Sep; 20(1):440. PubMed ID: 36180956
[TBL] [Abstract][Full Text] [Related]
11. FOXP3 promote the progression of glioblastoma via inhibiting ferroptosis mediated by linc00857/miR-1290/GPX4 axis.
Cao W; He Y; Lan J; Luo S; Sun B; Xiao C; Yu W; Zeng Z; Lei S
Cell Death Dis; 2024 Apr; 15(4):239. PubMed ID: 38561331
[TBL] [Abstract][Full Text] [Related]
12. Characterization of ferroptosis signature to evaluate the predict prognosis and immunotherapy in glioblastoma.
Zhu X; Zhou Y; Ou Y; Cheng Z; Han D; Chu Z; Pan S
Aging (Albany NY); 2021 Jul; 13(13):17655-17672. PubMed ID: 34244461
[TBL] [Abstract][Full Text] [Related]
13. A Ferroptosis-Related Prognostic Risk Score Model to Predict Clinical Significance and Immunogenic Characteristics in Glioblastoma Multiforme.
Xiao D; Zhou Y; Wang X; Zhao H; Nie C; Jiang X
Oxid Med Cell Longev; 2021; 2021():9107857. PubMed ID: 34804371
[TBL] [Abstract][Full Text] [Related]
14. HSP27 protects against ferroptosis of glioblastoma cells.
Yuan F; Sun Q; Zhang S; Ye L; Xu Y; Xu Z; Liu B; Zhang S; Chen Q
Hum Cell; 2022 Jan; 35(1):238-249. PubMed ID: 34791597
[TBL] [Abstract][Full Text] [Related]
15. Ginsenoside Rg5 inhibits glioblastoma by activating ferroptosis via NR3C1/HSPB1/NCOA4.
Zhang G; Hu J; Li A; Zhang H; Guo Z; Li X; You Z; Wang Y; Jing Z
Phytomedicine; 2024 Apr; 129():155631. PubMed ID: 38640858
[TBL] [Abstract][Full Text] [Related]
16. Fatostatin induces ferroptosis through inhibition of the AKT/mTORC1/GPX4 signaling pathway in glioblastoma.
Cai J; Ye Z; Hu Y; Ye L; Gao L; Wang Y; Sun Q; Tong S; Zhang S; Wu L; Yang J; Chen Q
Cell Death Dis; 2023 Mar; 14(3):211. PubMed ID: 36966152
[TBL] [Abstract][Full Text] [Related]
17. Juglone induces ferroptosis in glioblastoma cells by inhibiting the Nrf2-GPX4 axis through the phosphorylation of p38MAPK.
Guo F; Ling G; Qiu J; Li J; Gan Y; Yu Y; Tang J; Mo L; Piao H
Chin Med; 2024 Mar; 19(1):52. PubMed ID: 38520025
[TBL] [Abstract][Full Text] [Related]
18. CircLRFN5 inhibits the progression of glioblastoma via PRRX2/GCH1 mediated ferroptosis.
Jiang Y; Zhao J; Li R; Liu Y; Zhou L; Wang C; Lv C; Gao L; Cui D
J Exp Clin Cancer Res; 2022 Oct; 41(1):307. PubMed ID: 36266731
[TBL] [Abstract][Full Text] [Related]
19. SLC1A5 enhances malignant phenotypes through modulating ferroptosis status and immune microenvironment in glioma.
Han L; Zhou J; Li L; Wu X; Shi Y; Cui W; Zhang S; Hu Q; Wang J; Bai H; Liu H; Guo C; Cao H; Chao M; Hu Y; Mou Y; Jiao Y; Feng D; Wang L; Qu Y
Cell Death Dis; 2022 Dec; 13(12):1071. PubMed ID: 36566214
[TBL] [Abstract][Full Text] [Related]
20. Immunogenic cell death related risk model to delineate ferroptosis pathway and predict immunotherapy response of patients with GBM.
Feng S; Liang X; Li J; Wang Z; Zhang H; Dai Z; Luo P; Liu Z; Zhang J; Xiao X; Cheng Q
Front Immunol; 2022; 13():992855. PubMed ID: 36248827
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
